EMBL and COVID-19

EMBL has acted swiftly in response to COVID-19 by launching new initiatives and re-purposing existing facilities to provide a range of direct research and support services, including in collaboration with institutes in the Member States.

Image credit: Aleksandra Krolik/EMBL

How EMBL is working to tackle COVID-19

Our scientists and collaborators discuss how EMBL’s state-of-the-art facilities, expertise and service provisions have helped the global community tackle COVID-19.

Studying the COVID-19 spike protein

Gerhard Hummer and Martin Beck from the Max Planck Institute of Biophysics and Jacomina Krijnse Locker from the Paul Ehrlich Institute describe the insights gained on the COVID-19 spike protein and how EMBL’s expertise and infrastructure was essential for their work.

COVID-19 Data Platform: How it works

The COVID-19 Data Platform has secured valuable data submissions and made crucial data available to scientists around the world to help develop tests, treatments and a vaccine to stop the pandemic.

Understanding how coronavirus affects cell structures

EMBL electron microscopy specialists collaborate with researchers from Heidelberg University Hospital to understand the changes occurring in cell structures upon SARS-CoV-2 infection.

“We would not have progressed as fast without the imaging facility of EMBL.”
- Prof. Dr. Jacomina Krijnse Locker from the Paul Ehrlich Institute

Data resources

COVID-19 Data Platform

The COVID-19 Data Portal enables researchers to upload, access and analyse COVID-19 related reference data and specialist datasets as part of the wider European COVID-19 Data Platform.

RBPbase

RBPbase is a database of over 4000 RNA-binding proteins (RBPs) to assist researchers worldwide in the identification of proteins that interact with the SARS-CoV-2 RNA genome.

PDBe COVID-19 Portal

Observed ligand binding sites and protein-protein interaction residues.

UniProt COVID-19 Portal

The latest available pre-release UniProtKB data for the SARS-CoV-2 coronavirus.

Ensembl SARS-CoV-2 genome browser

The complete genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolate.

Open Targets COVID-19 target prioritisation tool

Integration of key datasets to identify and prioritise potential human and viral protein drug targets for COVID-19 treatments.

COVID-19 preprints in Europe PMC

Latest scientific publications and grants available in a single repository.

ChEMBL SARS-CoV-2 data

A summary of SARS-CoV-2 related bioactive molecules.


Scientific services

EMBL continues to provide many of our services in virtual and remote formats, to support research efforts efficiently and effectively during the pandemic.

Fully automated remote access to HTX

EMBL Grenoble’s fully automated protein- to-structure pipeline is available for external users and can be accessed via a mail-in sample service.

EMBL SPC facility supports COVID-19 projects

The Sample Preparation and Characterisation Facility at EMBL Hamburg is open to support scientists working on COVID-19 research. our programme to scientists virtually all over the globe.


EMBL status update

EMBL is supporting our Member States throughout the coronavirus pandemic, through direct activity, coordination of responses and data, and sharing of expert advice, as part of our mission to integrate European life science research.

Our sites at Barcelona, Grenoble, Hamburg, Heidelberg and Rome are partially open, and the EMBL-EBI site in Hinxton, UK, located on the Wellcome Genome Campus, is currently closed. EMBL-EBI staff continue to work from home to maintain the data resources and tools that EMBL-EBI provides to the life science community. EMBL management regularly reviews the situation at each site.


Training and conferences

EMBL continues to provide many of our training offerings, courses and conferences in virtual and remote formats, to continue to train and inspire the next scientific generation.

Bioinformatics training online

EMBL-EBI training enables scientists at all levels to get the most out of publicly available biological data, and continues to train scientists virtually.

Virtual school visits

The European Learning Laboratory for the Life Sciences (ELLS) – EMBL’s education facility – offers virtual guided tours of EMBL for school groups.


EMBL Response

EMBL’s efforts to fight COVID-19

More EMBL news relating to COVID-19
More EMBL news relating to COVID-19

Stay connected